Poster

Bridging Oncology and Autoimmune Disease: Using QSP to Select T-Cell Engager Doses by CRS Risk and Efficacy

Explore how QSP modeling informs T-cell engager dose selection for autoimmune diseases, balancing efficacy and…

Piet van der GraafOctober 26, 2026

Live Events

Certara Biotech Forum London: Building an Investor-Ready Strategy and Story

–

CertaraOctober 19, 2026

Conference

2nd Model-Informed Drug Development Summit

–

sarah CarrOctober 13, 2026

Webinar

From Data to Decisions: Getting More from Clinical Trial Evidence

Matt Zierhut, PhD MBAOctober 13, 2026

Fact Sheet

Drug-Drug Interaction (DDI) Calculator

The DDI Calculator within the Drug Interaction Database (DIDB) is a tool designed to quantitatively…

CertaraOctober 8, 2026

Publication

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Explore population PK modeling of dolutegravir in plasma and cerebrospinal fluid to characterize CNS penetration…

CertaraOctober 5, 2026

Publication

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

Explore a simultaneous population PK/PD model characterizing the dynamic relationships between belantamab mafodotin, sBCMA, and…

CertaraOctober 5, 2026

Conference

2nd TCE for Autoimmune Disease Summit

–

Danielle PillsburyOctober 5, 2026

White Paper

Model-Informed Strategies for ADC Development

Explore how model informed drug development can help ADC developers optimize dosing, reduce uncertainty, strengthen…

Danielle PillsburySeptember 22, 2026

Publication

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Research shows that particle- and protein-based extracellular vesicle dosing are not interchangeable, supporting a multidimensional…

CertaraSeptember 18, 2026

Model Informed Drug Development

Bridging Oncology and Autoimmune Disease: Using QSP to Select T-Cell Engager Doses by CRS Risk and Efficacy

Certara Biotech Forum London: Building an Investor-Ready Strategy and Story

2nd Model-Informed Drug Development Summit

From Data to Decisions: Getting More from Clinical Trial Evidence

Drug-Drug Interaction (DDI) Calculator

Population Pharmacokinetics of Dolutegravir in Plasma and Cerebrospinal Fluid in Adults Living With HIV

Simultaneous Population PKPD Analysis of Belantamab Mafodotin, Soluble BCMA, and Serum M-Protein in Relapsed/Refractory Multiple Myeloma

2nd TCE for Autoimmune Disease Summit

Model-Informed Strategies for ADC Development

When EV Dose Is Not What It Seems: Quantitative Mismatch Between Particle Number- and Protein-Based Dosing

Newsletter sign up

Quick links

Solutions

Contact